Ignite Creation Date:
2024-05-05 @ 11:46 PM
Last Modification Date:
2024-10-26 @ 10:39 AM
Study NCT ID:
NCT01414023
Status:
COMPLETED
Last Update Posted:
2020-05-18
First Post:
2011-08-09
Brief Title:
Assessing the Effects of a Neurobehavioral Intervention on Symptoms of Obsessive Compulsive Disorder
Sponsor:
Boston University Charles River Campus
Organization:
Boston University Charles River Campus
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2020-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CCT-OC
Brief Summary:
This experiment will examine if the use of computerized tasks that train individuals to control their attention more effectively will predict individual differences in obsessive-compulsive symptoms rumination and BDNF change After giving consent filling out self-report forms and giving blood for the BDNF test 80 participants will be randomized to Cognitive Control Training CCT or Peripheral Vision Task PVT described below which will be administered three times over a two week period At the third visit participants will also complete an anagram task and repeat the blood draw for BDNF testing The investigators hypothesize that computerized tasks that train individuals to control their attention more effectively will reduce Obsessive Compulsive OC symptoms Additionally individuals training in CCT will show increased ability to disengage from unattainable goals as assessed by responses to an unsolvable anagram task Finally individuals training in CCT will show a greater increase in BDNF levels as compared to individuals training in PVT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCT01414023 | REGISTRY | Clinical Trials | None |